Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunization, Secondary | 2 | 2013 | 16 | 0.630 |
Why?
|
| HIV Seropositivity | 2 | 2011 | 196 | 0.570 |
Why?
|
| HIV Infections | 5 | 2016 | 2586 | 0.480 |
Why?
|
| Antibodies, Bacterial | 2 | 2013 | 117 | 0.450 |
Why?
|
| Tetanus Toxoid | 1 | 2013 | 2 | 0.410 |
Why?
|
| Immunity, Maternally-Acquired | 2 | 2012 | 12 | 0.390 |
Why?
|
| Serotyping | 1 | 2012 | 37 | 0.370 |
Why?
|
| Streptococcus pneumoniae | 1 | 2012 | 34 | 0.370 |
Why?
|
| Pneumococcal Infections | 1 | 2012 | 33 | 0.360 |
Why?
|
| Fetal Blood | 1 | 2012 | 48 | 0.360 |
Why?
|
| Chickenpox | 1 | 2011 | 6 | 0.360 |
Why?
|
| Herpesvirus 3, Human | 1 | 2011 | 13 | 0.360 |
Why?
|
| HIV Seronegativity | 1 | 2011 | 41 | 0.350 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 376 | 0.340 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2011 | 117 | 0.340 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 367 | 0.340 |
Why?
|
| Measles | 1 | 2008 | 7 | 0.290 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2008 | 74 | 0.280 |
Why?
|
| Meningitis, Bacterial | 1 | 2006 | 11 | 0.240 |
Why?
|
| Salmonella | 1 | 2006 | 12 | 0.240 |
Why?
|
| Salmonella Infections | 1 | 2006 | 16 | 0.240 |
Why?
|
| Haemophilus influenzae type b | 1 | 2004 | 1 | 0.220 |
Why?
|
| Haemophilus Infections | 1 | 2004 | 4 | 0.220 |
Why?
|
| Vaccines, Conjugate | 1 | 2004 | 9 | 0.220 |
Why?
|
| Tennessee | 2 | 2016 | 93 | 0.210 |
Why?
|
| Pregnancy | 4 | 2020 | 1772 | 0.200 |
Why?
|
| Infant, Newborn | 3 | 2020 | 972 | 0.180 |
Why?
|
| Dexamethasone | 1 | 2020 | 55 | 0.160 |
Why?
|
| Glucocorticoids | 1 | 2020 | 91 | 0.160 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 65 | 0.160 |
Why?
|
| Prenatal Care | 1 | 2020 | 93 | 0.150 |
Why?
|
| Prevalence | 2 | 2016 | 1612 | 0.150 |
Why?
|
| Antibodies, Viral | 2 | 2011 | 306 | 0.140 |
Why?
|
| Infant | 2 | 2011 | 1175 | 0.110 |
Why?
|
| Humans | 8 | 2020 | 43102 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2013 | 1546 | 0.110 |
Why?
|
| Papillomaviridae | 1 | 2016 | 142 | 0.110 |
Why?
|
| Tetanus | 1 | 2013 | 3 | 0.100 |
Why?
|
| Female | 5 | 2020 | 24698 | 0.100 |
Why?
|
| Comorbidity | 1 | 2016 | 737 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 259 | 0.090 |
Why?
|
| Child | 2 | 2013 | 3443 | 0.090 |
Why?
|
| Antigens, Bacterial | 1 | 2012 | 144 | 0.090 |
Why?
|
| HIV | 1 | 2011 | 100 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2011 | 201 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1285 | 0.080 |
Why?
|
| Adolescent | 2 | 2016 | 6081 | 0.080 |
Why?
|
| Adult | 3 | 2020 | 13872 | 0.060 |
Why?
|
| Ceftriaxone | 1 | 2006 | 7 | 0.060 |
Why?
|
| Seizures | 1 | 2006 | 79 | 0.060 |
Why?
|
| HIV Antibodies | 1 | 2004 | 24 | 0.060 |
Why?
|
| Viral Load | 1 | 2004 | 348 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 432 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2020 | 21 | 0.040 |
Why?
|
| Stillbirth | 1 | 2020 | 20 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 36 | 0.040 |
Why?
|
| Developing Countries | 1 | 2020 | 113 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2020 | 134 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 287 | 0.040 |
Why?
|
| Premature Birth | 1 | 2020 | 95 | 0.040 |
Why?
|
| Male | 1 | 2006 | 23409 | 0.010 |
Why?
|